These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12486568)

  • 41. Botulinum toxin injection of the subscapularis muscle.
    Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
    J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of treatment with botulinum toxin on spasticity.
    Das TK; Park DM
    Postgrad Med J; 1989 Apr; 65(762):208-10. PubMed ID: 2594595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology].
    Jeppesen LL; Dalager T; Meden P
    Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776
    [No Abstract]   [Full Text] [Related]  

  • 44. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Gracies JM; Graham HK; Miyasaki JM; Naumann M; Russman B; Simpson LL; So Y;
    Neurology; 2008 May; 70(19):1691-8. PubMed ID: 18458229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin B treatment in children with spastic movement disorders: a pilot study.
    Schwerin A; Berweck S; Fietzek UM; Heinen F
    Pediatr Neurol; 2004 Aug; 31(2):109-13. PubMed ID: 15301829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin injection in patients with hereditary spastic paraparesis.
    Rousseaux M; Launay MJ; Kozlowski O; Daveluy W
    Eur J Neurol; 2007 Feb; 14(2):206-12. PubMed ID: 17250731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin A for spasticity, muscle spasms, and rigidity.
    Grazko MA; Polo KB; Jabbari B
    Neurology; 1995 Apr; 45(4):712-7. PubMed ID: 7723960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin: dosing and dilution.
    Francisco GE
    Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S30-7. PubMed ID: 15448575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury.
    Intiso D; Basciani M
    J Rehabil Med; 2009 Nov; 41(13):1100-2. PubMed ID: 19894009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The dosage of botulinum toxin type B in adductor type spasmodic dysphonia].
    Schönweiler R; Zwirner P
    HNO; 2005 Feb; 53(2):166-73. PubMed ID: 15060715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Medical care of patients with spasticity following stroke : Evaluation of the treatment situation in Germany with focus on the use of botulinum toxin].
    Kerkemeyer L; Lux G; Walendzik A; Wasem J; Neumann A
    Nervenarzt; 2017 Aug; 88(8):919-928. PubMed ID: 28289789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The risk-benefit of high doses of botulinum toxin injections for muscle spasticity ].
    Rousseaux M; Daveluy W
    Ann Readapt Med Phys; 2007 Jan; 50 Suppl 1():S1-3. PubMed ID: 17550809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity?
    Chan J; Winter A; Palit M; Sturt R; Graaff Sd; Holland AE
    Disabil Rehabil; 2013 Jun; 35(12):959-67. PubMed ID: 23025332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Botulinum toxin therapy for spasticity].
    Masakado Y
    Brain Nerve; 2014 Sep; 66(9):1039-47. PubMed ID: 25200575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuromuscular partitioning of subscapularis based on intramuscular nerve distribution patterns: implications for botulinum toxin injections.
    Warden JM; Roberts SL; Chang Y; Baker R; Boulias C; Ismail F; Agur AM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1408-15. PubMed ID: 24556271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.